RxDoctor Payments Data

Seamus Winters, PA

Physician Assistant · Horsham, PANPI 1497309850

Payments from drug & device makers

$1,828in general payments, 2019–2025

Across 46 payments — averaging $39.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Merck$314
  • E.r. Squibb & Sons, L.L.C.$278
  • Novartis$171
  • Amgen$162
  • Cvrx, Inc.$151
  • AstraZeneca$141
  • plus $611 from 11 others

What the payments were for

  • Food & beverage$1,828100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,828 in reported general payments places this provider in the 85th percentile of 6,643 physician assistant providers in Pennsylvania.

See all physician assistant providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$79,528
Medicare patients
563
Services billed
1,309

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban214$200,635
EntrestoSacubitril/Valsartan35$40,286
JardianceEmpagliflozin22$20,671
Metoprolol Succinate187$2,858
Dabigatran EtexilateDabigatran Etexilate Mesylate11$1,802
Atorvastatin Calcium90$1,644
Diltiazem 24hr Er (Cd)Diltiazem Hcl18$1,106
Flecainide Acetate33$1,059
Amiodarone Hcl44$905
Bumetanide12$790
Nadolol30$783
ClopidogrelClopidogrel Bisulfate38$733
Nifedipine ErNifedipine20$722
Losartan Potassium56$688
Carvedilol69$572

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$16$200,635214 claims
NovartisEntresto$171$40,28635 claims
Boehringer IngelheimJardiance$39$20,67122 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 6,643 physician assistant providers in Pennsylvania.

Other physician assistant in Horsham

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →